NextCell Pharma
The Board of Directors and management sign in addition to subscription commitments
In addition to the previously entered subscription undertakings of approximately SEK 1.5 million, the Board of Directors, management and key employees of the Company have subscribed with and without preferential rights for an additional approximately SEK 0.8 million. Furthermore, former Chairman of the Board Anders Essen-Möller has stated that he will subscribe for units for a total of approximately SEK 2.0 million, corresponding to SEK 1.0 million in addition to his subscription commitment.
The above means that all members of NextCell's board of directors and management with shareholdings in the Company have applied for subscription in addition to their respective pro-rata shares of the rights issue. Today is the last day of trading in unit rights. The subscription period in the rights issue ends June 14, 2024.
Datum | 2024-06-11, kl 13:00 |
Källa | Cision |
![](https://static.allaaktier.se/ads/hand-waving-2.png)